Mandatory information

mandatory information Veno SL® 300

Veno SL® 300
Active ingredient: troxerutine. Therapeutic indications: As supportive treatment against accumulation of liquids in tissue (exudative processes), for the stabilization of fine, brittle blood vessels (capillary fragility). For information on risks and side effects read the package leaflet and ask your doctor or pharmacist. February 2019
URSAPHARM Arzneimittel GmbH, Industriestraße 35, 66129 Saarbrücken, Germany

View all madatory information